newsfilter
← Latest News
GlobeNewswire·

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI)Previous clinical trial data on IMM-529 provides